Evidence map›Paper›PMID 25839897›Full record

ArticleNeuropharmacology2015

Role of interleukin-1 receptor signaling in the behavioral effects of ethanol and benzodiazepines.

Yuri A Blednov, Jillian M Benavidez, Mendy Black, Jody Mayfield, R Adron Harris

Abstract read
In one paragraph

Article in Neuropharmacology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
2.2field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 32 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Adolescent neuroimmune function and its interaction with alcohol.International review of neurobiology · 2022
    Review
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Neuroimmune signaling in alcohol use disorder.Pharmacology, biochemistry, and behavior · 2019
    Review
  15. Review
  16. Article
  17. Article
  18. Ethanol and Cytokines in the Central Nervous System.Handbook of experimental pharmacology · 2018
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Yuri A BlednovWaggoner Center for Alcohol and Addiction Research, The University of Texas at Austin, Austin, TX 78712, USA.
Jillian M BenavidezWaggoner Center for Alcohol and Addiction Research, The University of Texas at Austin, Austin, TX 78712, USA.
Mendy BlackWaggoner Center for Alcohol and Addiction Research, The University of Texas at Austin, Austin, TX 78712, USA.
Jody MayfieldWaggoner Center for Alcohol and Addiction Research, The University of Texas at Austin, Austin, TX 78712, USA.
R Adron HarrisWaggoner Center for Alcohol and Addiction Research, The University of Texas at Austin, Austin, TX 78712, USA. Electronic address: harris@austin.utexas.edu.
The University of Texas at Austin · US

Funding

INIA: ANIMAL COREU01AA013520 · NIAAA · UNIVERSITY OF TEXAS AUSTIN · PI YURI A BLEDNOV, ROBERT O. MESSING · 2001 to 2026
$9.5M
BRAIN MEMBRANES IN ALCOHOL AND BENZODIAZEPINE DEPENDENCER01AA006399 · NIAAA · UNIVERSITY OF TEXAS AUSTIN · PI HARRIS, ROBERT A · 1985 to 2018
$8.8M
BRAIN MEMBRANES IN ALCOHOL AND BENZODIAZEPINE DEPENDENCER37AA006399 · NIAAA · UNIVERSITY OF TEXAS AUSTIN · PI HARRIS, ROBERT ADRON · 1989 to 1998
–
NIAAA NIH HHS AA006399NIAAA NIH HHS AA013520NIAAA NIH HHS R01 AA006399NIAAA NIH HHS R37 AA006399NIAAA NIH HHS U01 AA013520
6 · The paper itself

Abstract

Gene expression studies identified the interleukin-1 receptor type I (IL-1R1) as part of a pathway associated with a genetic predisposition to high alcohol consumption, and lack of the endogenous IL-1 receptor antagonist (IL-1ra) strongly reduced ethanol intake in mice. Here, we compared ethanol-mediated behaviors in mice lacking Il1rn or Il1r1. Deletion of Il1rn (the gene encoding IL-1ra) increases sensitivity to the sedative/hypnotic effects of ethanol and flurazepam and reduces severity of acute ethanol withdrawal. Conversely, deletion of Il1r1 (the gene encoding the IL-1 receptor type I, IL-1R1) reduces sensitivity to the sedative effects of ethanol and flurazepam and increases the severity of acute ethanol withdrawal. The sedative effects of ketamine and pentobarbital were not altered in the knockout (KO) strains. Ethanol intake and preference were not changed in mice lacking Il1r1 in three different tests of ethanol consumption. Recovery from ethanol-induced motor incoordination was only altered in female mice lacking Il1r1. Mice lacking Il1rn (but not Il1r1) showed increased ethanol clearance and decreased ethanol-induced conditioned taste aversion. The increased ethanol- and flurazepam-induced sedation in Il1rn KO mice was decreased by administration of IL-1ra (Kineret), and pre-treatment with Kineret also restored the severity of acute ethanol withdrawal. Ethanol-induced sedation and withdrawal severity were changed in opposite directions in the null mutants, indicating that these responses are likely regulated by IL-1R1 signaling, whereas ethanol intake and preference do not appear to be solely regulated by this pathway.

Indexed as

Alcohol DrinkingAnimalsAvoidance LearningBehavior, AnimalBenzodiazepinesEthanolFemaleFlurazepamHypnotics and SedativesInterleukin 1 Receptor Antagonist ProteinKetamineMaleMice, 129 StrainMice, Inbred C57BLMice, KnockoutMotor ActivityBenzodiazepinesEthanolFlurazepamHypnotics and SedativesIL1R1 protein, mouseIl1rn protein, mouseInterleukin 1 Receptor Antagonist ProteinKetaminePentobarbitalReceptors, Interleukin-1 Type IAlcohol withdrawalAnakinraConditioned taste aversionDrinking in the darkFlurazepamIl1r1IL-1R1IL-1raIl1rnKineretKnockout miceLoss of righting reflexTwo-bottle choice

Identifiers

PMID25839897
PMCPMC4465986
OpenAlexW1963646496

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.